The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cells
Antonietta Santoro(University of Salerno), Maurizio Bifulco(University of Naples Federico II)
Cited by 14
Related Papers
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
|Oncotarget|2015|54
Antiglioma effects of<scp>N</scp>6‐isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptor
|International Journal of Cancer|2016|34